← SynDRA
NSC-663284
SynDRA canonical compound SYN1968797 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CDC25A | CDC25B | CDC25C |
|---|
| Mechanism of action | CDC inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- NSC 663284
- NSC663284
- CDC25 Phosphatase Inhibitor II, NSC 663284
- 6-Chloro-7-(2-morpholin-4-yl-ethylamino)quinoline-5,8-dione
- 6-chloro-7-{[2-(morpholin-4-yl)ethyl]amino}quinoline-5,8-dione
- DA3003-1
- 6-Chloro-7-((2-morpholinoethyl)amino)quinoline-5,8-dione
- AC1Q3HBF
- AC1Q3HBE
- SPS8I1
- MLS006010693
- SCHEMBL2556224
- AC1L8E02
- CTK4H9880
- CHEBI:92053
- DTXSID50327512
- MolPort-003-983-788
- HMS3268K22
- BCP16027
- MFCD08276924
- BS0130
- ZINC100002044
- AKOS024456823
- CS-7519
- NCGC00092289-01
- NCGC00092289-02
Look up NSC-663284 in the interactive SynDRA portal →